期刊文献+

有氧运动对非酒精性脂肪性肝病疗效的Meta分析 被引量:6

Effect of aerobic exercise in non-alcoholic fatty liver disease patients: a Meta-analysis
下载PDF
导出
摘要 目的探讨有氧运动是否能预防或改善非酒精性脂肪性肝病(non-alcoholic fatty liver disease,NAFLD),评估患者在接受有氧运动后,能否对肝脏脂肪、肝功能、血脂、体质量等产生影响。方法根据纳入标准确定检索词,对相关数据库搜索后,选择有氧运动与NAFLD对比或控制性的随机性研究。提取文章数据、纳入研究方法学和质量评估工作由2名作者分别进行。以Cochrane系统评价手册为指导方针进行纳入研究的资料提取及质量评价,使用Rev Man 5.2软件进行Meta分析。结果该研究共纳入文献6篇,包含206例患者,得出结果:有氧运动对NAFLD的肝内脂肪(intrahepatic lipid,IHL)有明显的缓解作用(MD=-3.29,95%CI:-5.53^-1.05,P=0.004)。有氧运动对NAFLD患者的丙氨酸氨基转移酶(alanine aminotransferase,ALT)差异无统计学意义(SMD=0.12,95%CI:-0.23~0.48,P=0.49);有氧运动对天门冬氨酸氨基转移酶(aspartate aminotransferase,AST)没有缓解作用(SMD=0.27,95%CI:-0.11~0.65,P=0.16);有氧运动对患者血脂包括甘油三酯(triglyceride,TG)、总胆固醇(total cholesterol,TC)、高密度脂蛋白(high density lipoprotein,HDL)及低密度脂蛋白(low density lipoprotein,LDL)的改善差异无明显统计学意义(TG:SMD=-0.04,95%CI:-0.40~0.32,P=0.93;TC:SMD=-0.33,95%CI:-0.68~0.02,P=0.06;HDL:SMD=0.02,95%CI:-0.31~0.35,P=0.90;LDL:SMD=-0.07,95%CI:-0.42~0.28,P=0.68)。有氧运动对NAFLD患者的体质量指数(body mass index,BMI)也无明显降低(MD=0.33,95%CI:-2.50~3.17,P=0.82)。结论有氧运动可以明显改善NAFLD患者的IHL,但对肝功能、血脂、BMI等方面并无明显改善,这与研究的设计有很大关系。我们仍需进一步探讨如何调整有氧运动的内容结构,及如何利用其改变生活方式以改善NAFLD患者的病情。 Objective To investigate whether aerobic exercise can prevent or improve the condition of non-alcoholic fatty liver disease( NAFLD),and evaluate the efficacy of indicators including liver fat,liver function,blood fat and body mass after accepting the intervention. Methods According to the inclusion criteria,random and controlled trials of aerobic exercise combined with NAFLD were chosen. Data extraction of articles and methodology of included research and quality evaluation were carried out by two authors. Regard Cochrane reviewer handbook as guidelines for the assessment of extracting data,Rev Man 5. 2 software was used for Meta analysis. Results This study included 6 researches including 206 patients. Aerobic exercise could improve IHL of NAFLD patients( MD =- 3. 29,95 % CI:- 5. 53 -- 1. 05,P = 0. 004). However,the exercise alone vs control( without diet intervention or other interventions in both groups),there was no significant efficacy on liver function,blood fat and body mass index( BMI),respectively( ALT:SMD = 0. 12,95% CI:- 0. 23 - 0. 48,P = 0. 49; AST: SMD = 0. 27,95 % CI:- 0. 11 - 0. 65,P = 0. 16; TG:SMD =- 0. 04,95% CI:- 0. 40 - 0. 32,P = 0. 93; TC: SMD =- 0. 33,95% CI:- 0. 68 - 0. 02,P = 0. 06;HDL: SMD = 0. 02,95% CI:- 0. 31 - 0. 35,P = 0. 90; LDL: SMD =- 0. 07,95% CI:- 0. 42 - 0. 28,P = 0. 68;BMI: MD = 0. 33,95% CI:- 2. 50 - 3. 17,P = 0. 82). Conclusion Aerobic exercise can improve the condition of NAFLD on IHL instead of liver functions,blood fat and BMI. The structure of aerobic exercise and how to use the interventions of lifestyle are worthy of further exploration.
出处 《胃肠病学和肝病学杂志》 CAS 2016年第4期398-404,共7页 Chinese Journal of Gastroenterology and Hepatology
基金 省科技重大(1302FKDA029)
关键词 非酒精性脂肪性肝病 有氧运动 随机对照试验 META分析 Non-alcoholic fatty liver disease Aerobic exercise Randomized controlled trial Meta-analysis
  • 相关文献

参考文献29

  • 1Fabbrini E, Mohammed BS, Magkos F, et al. Alterations in adiposetissue and hepatic lipid kinetics in obese men and women with nonalco- holic fatty liver disease [ J ]. Gastroenterology, 2008, 134 ( 2 ) .. 424-431.
  • 2常彬霞,滕光菊,邹正升,李保森.非酒精性脂肪性肝病的研究进展[J].传染病信息,2011,24(5):309-313. 被引量:8
  • 3Starley BQ, Calcagno C J, Harrison SA. Nonalcoholic fatty liver disease and hepatocellular carcinoma: a weighty connection [ J ]. Hepatology, 2010, 51(5) : 1820-1832.
  • 4Anstee QM, Targher G, Day CP. Progression of NAFLD to diabetes mellitus, cardiovascular disease or cirrhosis [ J ]. Nat Rev Gastroen- terol Hepatol, 2013, 10(6) : 330-344.
  • 5Americans PAGF. 2008 Physical activity guidelines for Americans [ M ]. Human Kinetics Inc, 2008: 25.
  • 6Koot BG, van der Baan-Slootweg OH, Tamminga-Smeulders CL, et al. Lifestyle intervention for non-alcoholic fatty liver disease: prospective cohort study of its efficacy and factors related to improvement [ J ]. Arch Dis Child, 2011, 96(7) : 669-674.
  • 7Caldwell S, Lazo M. Is exercise an effective treatment for NASH? Knowns and unknowns [ J ]. Ann Hepatol, 2009, 8 Suppl 1: $60-$66.
  • 8Sullivan S, Kirk EP, Mittendorfer B, et al. Randomized trial of exer- cise effect on intrahepatic triglyceride content and lipid kinetics in non- alcoholic fatty liver disease[J].Hepatology, 2012, 55 ( 6 ) : 1738-1745.
  • 9Chen SM, Liu CY, Li SR, et al. Effects of therapeutic lifestyle pro- gram on ultrasound-diagnosed nonalcoholic fatty liver disease [ J 1. J Chin Med Assoe, 2008, 71(11) : 551-558.
  • 10Keating SE, Hackett DA, Parker HM, et al. Effect of aerobic exer- cise training dose on liver fat and visceral adiposity [ J]. J Hepatol, 2015, 63(1) : 174-182.

二级参考文献54

  • 1朱虹,李卫平,李启富,沈飞霞,倪连松,汪大望.PCOS患者血清RBP4浓度测定及其与胰岛素抵抗的相关性研究[J].浙江医学,2009(12). 被引量:1
  • 2艾正琳,陈东风.SREBP-1c在大鼠非酒精性脂肪性肝病中的表达及意义[J].第三军医大学学报,2006,28(10):1063-1065. 被引量:35
  • 3吴海娅,贾伟平,魏丽,陆俊茜,包玉倩,项坤三.肥胖及2型糖尿病患者血清视黄醇结合蛋白4水平的变化及其临床意义[J].中华内分泌代谢杂志,2006,22(3):290-293. 被引量:95
  • 4Browning JD, Szczepaniak LS, Dobbins R, et ol. Prevalence of he- patic steatosis in an urban population in the United States: impact of ethnicity[J ]. Hepatology, 2004, 40(6): 1387-1395.
  • 5Bellentani S, Saccoccio G, Masutti F, et al. Prevalence of and risk factors for hepatic steatosis in Northern Italy[J]. Ann Intern Med, 2000, 132(2):112-117.
  • 6Fan JG, Zhu J, Li X J, et al. Prevalence of and risk factors for fatty liver in a general population of Shanghai, China[J]. J Hepatol, 2005, 43(3):508-514.
  • 7Jimba S, Nakagami T, Takahashi M, et al. Prevalence of non- alcoholic fatty liver disease and its association with impaired glu- cose metabolism in Japanese adults[Jl. Diabet Med, 2005, 22(9): 1141-1145.
  • 8Schwimmer J, Deutsch R, Kahen T, et al. Prevalence of fatty liver in children and adolescents[J]. Pediatrics, 2006, 118(4):1388-1393.
  • 9Bellentani S, Saccoccio G, Masutti F, et al. Prevalence of and risk factors for hepatic steatosis in Northern Italy[J]. Ann Intern Med, 2000, 132(2): 112-117.
  • 10Dam-Larsen S, Franzmann M, Andersen IB, et ol. Long term prognosis of fatty liver: risk of chronic liver disease and death[J]. Gut, 2004, 53(5):750-755.

共引文献49

同被引文献81

引证文献6

二级引证文献10

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部